Skip to search formSkip to main contentSkip to account menu

Ispinesib Mesylate

The mesylate salt form of ispinesib, a synthetic small molecule, derived from quinazolinone, and kinesin spindle protein (KSP) inhibitor, with… 
National Institutes of Health

Related topics

Related topics

1 relation
ispinesib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Phase I trials in patients with salivary gland cancers (SGCs): The Cancer Therapy and Research Center (CTRC) experience.
e16017 Background: SGCs are rare neoplasms with variable clinical behavior where cytotoxic chemotherapy is palliative for some… 
2010
2010
Gateways to clinical trials.
[¹¹C]RAC; (18)F-Fluoromisonidazole; 89-12; 9-[¹⁸F]Fluoropropyl-(+)-dihydrotetrabenazine; Adalimumab, Adecatumumab, ADMVA, ADXS-11… 
2008
2008
A pediatric phase I trial and pharmacokinetic (PK) study of sunitinib: A Children's Oncology Group Phase I Consortium study
3561 Background: Sunitinib is an oral multitargeted tyrosine kinase inhibitor of VEGF, PDGF, c-KIT, and flt-3 receptors. This… 
2008
2008
Gateways to clinical trials. July-August 2008.
(-)-Epigallocatechin gallate, 501516, 89-12; Abatacept, Adalimumab, Adefovir dipivoxil, AG-701, Agatolimod sodium, Alefacept… 
2008
2008
Gateways to clinical trials.
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following… 
2007
2007
Gateways to clinical trials.
Agomelatine, AGRO-100, AIDSVAX gp120 B/E, alfimeprase, aliskiren fumarate, ALVAC vCP1452, alvocidib hydrochloride, ambrisentan… 
2006
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)